Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients

Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients

Novel coronavirus disease (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Its impact on patients with comorbidities is clearly related to fatality cases, and diabetes has been linked to one of the most important causes of severity and morta...

Full description

Bibliographic Details
Main Authors: Tales Lyra Oliveira, Igor Santana Melo, Léia Cardoso-Sousa, Igor Andrade Santos, Mohamad Bassim El Zoghbi, Caroline Gusson Shimoura, Renata Pereira Georjutti, Olagide Wagner Castro, Luiz Ricardo Goulart, Ana Carolina Gomes Jardim, Thúlio Marquez Cunha, Robinson Sabino-Silva
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Physiology
Subjects:
betacoronavirus infection
angiotensin-converting enzyme
SGLT1
diabetes mellitus
pneumonia
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2020.587013/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2020.587013/full

Similar Items